Immune System Buster - FIGTH COVID with your own POWER - SARARU OILS


Available On Order

Regular price 377.00

Tax included.

The swisscbd® oil drops are used in many areas and can support the well-being of the user. The pure CBD substance used for our drops has a purity of> 99% and is produced under GMP conditions. The drops are odorless and tasteless, as well as available with a mint or orange aroma. 

The swisscbd® oil drops are available in three concentrations: 

Basic: 5% with 500mg CBD - corresponds to approx.1.1 mg CBD per drop

Middle: 10% with 1000mg CBD - corresponds to approx.2.2 mg CBD per drop

Strong: 15% with 1500mg CBD - corresponds to approx.3.3 mg CBD per drop


The swisscbd® drops do not contain THC!



Start with 1-3 drops per application. Drizzle the swisscbd® drops directly onto the tongue or onto a spoon and spread / rub on the gums with the tongue. After that, do not eat or drink for 10 minutes. After 1-2 days, increase the number of drops per application gradually by 1-2 drops until the desired result is achieved. Depending on the intended use, the drops are used 1-3 times a day. The absorption of the CBD via the oral mucosa takes about 5-15 minutes. When using swisscbd® drops, it is recommended to keep a "diary" about the time / number of drops / sensation until the number of drops / number of applications per day achieved for the desired result is clear.


Describes special ingredients



Because of its properties, cannabidiol (CBD) can contribute significantly to the well-being of the user 1 .


MCT oil

The abbreviation MCT stands for "medium chain triglycerides" (German: MKT, Mittelkettige

Triglycerides). These are triglycerides (or MCT fats)

contain medium chain fatty acids. MCT oil is used in the swisscbd® oil drops

because it has a very low allergenic potential as well as odorless and

is tasteless.


More information:

A bottle of swisscbd® oil drops (10ml) contains approx. 450 drops. This refers to use at room temperature and the bottle (with dropper) or pipette is held vertically. At lower temperatures, a change in the viscosity of the carrier can result in a deviation.



1. At this point it should be explicitly pointed out that these products are not considered medicinal products in Switzerland and therefore no promise of healing can be made. However, the studies below also indicate the medical potential that CBD can offer.

Devinsky O. et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 2014

Fernández-Ruiz J. et al. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? Br J Clin Pharmacol, 2013

Prud'homme M., Cata R., Jutras-Aswad D. Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence. Subst Abuse, 2015

Schier AR et al. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug. ev Bras Psiquiatr, 2012

Zuardi AW et al. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res, 2006

Zuardi AW Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr, 2008

Carlini EA et al., Hypnotic and antiepileptic effects of cannabidiol, 1981

Lynch ME et al., A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapyinduced neuropathic pain, 2014

For pharmacists, please also note the following information (we keep it updated): Swissmedic, products with cannabidiol (CBD) overview and enforcement aid




Delivery time1-2 days

CBD content amount of CBD 5% - 500mg, 10% - 1000 mg, 15% - 1500 mg

Test Parameter Method Specification Results


Appereance Visual control

White to yellow powder


    Identity Ph. Eur. 2.2.24 (IR) R2 > 95 % 

    CBD-Content Ph. Eur. 2.2.29 (HPLC) 98.0 to 102.0 % (m/m) 


Sum of all impurities

Ph. Eur. 2.2.29 (HPLC)

Total impurities* ≤ 0.5 % m/m


Related substances

Unspecified impurities each ≤ 0.10 % m/m


Specific rotation

Ph. Eur. 2.2.7 (Polarimetry)

-129.5 to -135.0 

Sulfate ash Ph. Eur. 2.4.14 ≤ 0.1 % (m/m)    *Disregard limit for impurities = 0.05%


Residual solvents

Ph. Eur. 5.4 / PVS_20 (Loss on drying)

< 0.5 % (m/m) 

Water content

Ph. Eur. 2.5.12 (Coulometry)

< 0.1 % (m/m)